ABVC BioPharma, Inc. (ABVC)
1.03
+0.06
(+6.32%)
USD |
NASDAQ |
Nov 09, 16:00
1.03
0.00 (0.00%)
After-Hours: 18:02
ABVC BioPharma Gross Profit (Annual) : -0.5048M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.5048M |
| December 31, 2024 | 0.3079M |
| December 31, 2023 | -0.53M |
| December 31, 2022 | 0.6596M |
| December 31, 2021 | 0.3387M |
| December 31, 2020 | 0.4272M |
| December 31, 2019 | 0.6265M |
| December 31, 2018 | -0.2219M |
| December 31, 2017 | 0.00 |
| September 30, 2016 | 0.00 |
| September 30, 2015 | 0.00 |
| September 30, 2014 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2013 | 0.00 |
| September 30, 2012 | 0.00 |
| September 30, 2011 | -0.031M |
| September 30, 2010 | -0.0304M |
| September 30, 2009 | -1.526M |
| September 30, 2008 | -0.0124M |
| September 30, 2007 | 0.0289M |
| September 30, 2006 | 0.0418M |
| September 30, 2005 | 0.0167M |
| December 31, 2004 | 0.0251M |
| December 31, 2003 | -0.0121M |
| December 31, 2002 | 0.0006M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Anika Therapeutics, Inc. | 63.81M |
| Perspective Therapeutics, Inc. | -2.367M |
| MiMedx Group, Inc. | 344.21M |
| Abbott Laboratories | 23.37B |
| AngioDynamics, Inc. | 164.21M |